Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

C3 AI Reports Strong Financial Results and Industry Expansion in Q3 Fiscal 2024

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Technology Artificial intelligence Markets and money
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

The Latin America distributor for Iveda is expecting to generate $6 million in revenue for the fiscal year 2024, along with an additional $30 million in recurring revenue over the next five years. This positive forecast comes after a series of successful efforts and presentations in 2023 that have positioned the company for ongoing success.

In other news, C3 AI, a leading player in the AI industry, has unveiled its financial results for the third quarter of fiscal 2024. The company posted a total revenue of $78.4 million for the quarter, representing an 18% increase from the previous year. Subscription revenue made up $70.4 million, accounting for 90% of the total revenue and reflecting a 23% increase from the prior year. C3 AI’s partner-supported bookings saw significant growth, with a 337% year-over-year increase and a 62% quarter-over-quarter increase. The company finalized 27 agreements through its partner network in Q3, including partnerships with AWS and Baker Hughes.

Moreover, C3 AI has expanded its presence across various industries, with notable bookings distribution by sector in Q3 as follows:
– State and Local Government: 29%
– Federal: 25%
– Manufacturing: 16%
– Agriculture: 11%
– Chemicals: 8%
– Professional Services: 7%
– Energy and Utilities: 2%
– Food Processing and Consumer Packaged Goods: 1%
– Oil and Gas: 1%

Looking ahead, C3 AI has provided guidance for the fourth quarter of fiscal 2024 and the full year fiscal 2024, outlining expectations for total revenue and operational losses in different departments.

IVDA Stock Fluctuates on February 28th: Analysis and Outlook for Investors

On February 28, 2024, IVDA stock experienced fluctuations in its performance. IVDA is currently trading in the middle of its 52-week range and above its 200-day simple moving average, indicating relative stability over the long term.

IVDA shares saw a decrease in price on that day, closing at $0.97, a $0.02 drop from the previous market close, representing a 2.02% decrease in value.

Despite the drop during regular market hours, IVDA saw a slight increase in after-hours trading, rising by $0.04, indicating renewed interest among investors.

Overall, IVDA’s performance on February 28th was mixed, with a slight decrease during regular trading hours followed by a modest increase in after-hours trading. Investors will be monitoring closely to see how the stock performs in the coming days and if it can maintain its position above its 200-day moving average.

IVDA Stock Performance and Financial Results for 2024: Revenue Up, Net Income Down

IVDA stock had a mixed performance on February 28, 2024, as the company reported its financial results for the past year and the third quarter. According to data from CNN Money, IVDA’s total revenue stood at $4.47 million for the past year, representing a significant increase of 132.98% compared to the previous year. However, the total revenue for the third quarter was $872.76 thousand, showing a decrease of 63.51% compared to the previous quarter.

In terms of net income, IVDA reported a loss of $3.35 million for the past year and a loss of $828.82 thousand for the third quarter. This represents a decrease of 11.56% in net income compared to the previous year and a decrease of 9.43% compared to the previous quarter.

Earnings per share (EPS) for IVDA were reported at -$0.26 for the past year and -$0.05 for the third quarter. Despite the overall negative EPS, there was a 22.36% increase in EPS compared to the previous year. However, EPS decreased by 9.05% compared to the previous quarter.

Tags: IVDA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Mining Markets and money

Foremost Lithiums Proposal for Infrastructure Enhancement in Manitobas Snow Lake Region A Step Towards Sustainable Development

Adial Pharmaceuticals Expands Intellectual Property Portfolio for AD04 Treatment of Opioid Use Disorder

Analyst Ratings and Price Targets for Viridian Therapeutics

Recommended

Emergent BioSolutions Stock

A Tale of Two Realities: Emergent BioSolutions’ Social Mission and Financial Strain

4 weeks ago
Food Retailers Stock Bull Market

JP Morgan Analyst Maintains Neutral Rating on Tyson Foods with Revised Price Target

2 years ago
MMM stock news

Bearish Sentiment Surrounds Air Lease NYSE AL Trading

2 years ago
QuantumScape Stock

QuantumScape Leadership Executes Major Stock Sales, Raising Investor Concerns

5 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

Leadership Crisis at Nestlé Sparks Investor Concerns

Standex Shares Plunge Amid Technical Warnings and Insider Selling

Navigating Credit Headwinds: Synchrony’s Strategic Expansion Amid Sector Challenges

Tech Sector Surge: AI and Cloud Computing Fuel Vanguard ETF’s Record Run

Trending

Pfizer Stock
Healthcare

Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena

by Dieter Jaworski
September 22, 2025
0

In a move signaling its serious intent to capture a share of the lucrative anti-obesity drug market,...

Nike Stock

Nike Shares Face Critical Earnings Test

September 22, 2025
Tutor Perini Stock

Insider Sales at Tutor Perini Coincide with Stock Peak

September 22, 2025
Ubiquiti Stock

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

September 22, 2025
BioNTech Stock

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena
  • Nike Shares Face Critical Earnings Test
  • Insider Sales at Tutor Perini Coincide with Stock Peak

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com